Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal platelet function (HP:0011869)help
Parent Node:
expand
Abnormal platelet aggregation (HP:0030402)help
..Starting node
..expand
Impaired platelet aggregation (HP:0003540)help
Term ID: 3540
Name: Impaired platelet aggregation
Synonym: Defective platelet aggregation; Deficient platelet aggregation; Platelet aggregation defect
Definition: An impairment in the rate and degree to which platelets aggregate after the addition of an agonist that stimulates platelet clumping. Platelet aggregation is measured using aggregometer to measure the optical density of platelet-rich plasma, whereby platelet aggregation causes the plasma to become more transparent.
Comments:
Reference: HP:0003540
Genes and Diseases:
 
       Child Nodes:
........expandImpaired ADP-induced platelet aggregation (HP:0004866) help
........expandImpaired epinephrine-induced platelet aggregation (HP:0008148) help
........expandImpaired collagen-induced platelet aggregation (HP:0008320) help
........expandImpaired arachidonic acid-induced platelet aggregation (HP:0011870) help
........expandImpaired ristocetin-induced platelet aggregation (HP:0011871) help
........expandImpaired thrombin-induced platelet aggregation (HP:0011872) help
........expandImpaired thromboxane A2 agonist-induced platelet aggregation (HP:0011894) help
........expandImpaired convulxin-induced platelet aggregation (HP:0031127) help
........expandImpaired collagen-related peptide-induced platelet aggregation (HP:0031128) help
........expandImpaired phorbol myristate acetate-induced platelet aggregation (HP:0031129) help
........expandImpaired calcium ionophore-induced platelet aggregation (HP:0031130) help

 Sister Nodes: 
..expandIncreased RIPA (HP:0040241) help
..expandSpontaneous platelet aggregation (HP:0030403) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003540HP:0003540Impaired platelet aggregation0ABCG8 CL E G H6424113887OMIM:210250Sitosterolemia 1.76
HP:0003540HP:0003540Impaired platelet aggregation0AP3B1 CL E G H8546566OMIM:608233Hermansky-Pudlak syndrome 283
HP:0003540HP:0003540Impaired platelet aggregation0BLOC1S3 CL E G H38855220914OMIM:614077Hermansky-Pudlak syndrome 8.42
HP:0003540HP:0003540Impaired platelet aggregation0BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0003540HP:0003540Impaired platelet aggregation0CALR CL E G H8111455OMIM:187950THROMBOCYTHEMIA 1; THCYT11
HP:0003540HP:0003540Impaired platelet aggregation0CISD2 CL E G H49385624212OMIM:604928Wolfram syndrome 23
HP:0003540HP:0003540Impaired platelet aggregation0DTNBP1 CL E G H8406217328OMIM:614076Hermansky-Pudlak syndrome 7.46
HP:0003540HP:0003540Impaired platelet aggregation0EPHB2 CL E G H20483393OMIM:618462Bleeding disorder, platelet-type, 227
HP:0003540HP:0003540Impaired platelet aggregation0FLI1 CL E G H23133749OMIM:617443Bleeding disorder, platelet-type, 21.8
HP:0003540HP:0003540Impaired platelet aggregation0GATA1 CL E G H26234170OMIM:300835Anemia, X-linked, with or without neutropenia and/or platelet abnormalitiesHP:0040283 - Occasional29
HP:0003540HP:0003540Impaired platelet aggregation0GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0003540HP:0003540Impaired platelet aggregation0GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndrome23
HP:0003540HP:0003540Impaired platelet aggregation0GP1BA CL E G H28114439OMIM:231200BERNARD-SOULIER SYNDROME; BSS23
HP:0003540HP:0003540Impaired platelet aggregation0GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndrome8
HP:0003540HP:0003540Impaired platelet aggregation0GP1BB CL E G H28124440OMIM:231200BERNARD-SOULIER SYNDROME; BSS8
HP:0003540HP:0003540Impaired platelet aggregation0GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndrome21
HP:0003540HP:0003540Impaired platelet aggregation0GP9 CL E G H28154444OMIM:231200BERNARD-SOULIER SYNDROME; BSS21
HP:0003540HP:0003540Impaired platelet aggregation0HPS3 CL E G H8434315597OMIM:614072Hermansky-Pudlak syndrome 367
HP:0003540HP:0003540Impaired platelet aggregation0HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5105
HP:0003540HP:0003540Impaired platelet aggregation0HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0003540HP:0003540Impaired platelet aggregation0IKZF5 CL E G H6437614283OMIM:619130THROMBOCYTOPENIA 7; THC7
HP:0003540HP:0003540Impaired platelet aggregation0ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 16.69
HP:0003540HP:0003540Impaired platelet aggregation0ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia.69
HP:0003540HP:0003540Impaired platelet aggregation0ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombasthenia69
HP:0003540HP:0003540Impaired platelet aggregation0ITGB3 CL E G H36906156OMIM:619271BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT2480
HP:0003540HP:0003540Impaired platelet aggregation0ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombasthenia80
HP:0003540HP:0003540Impaired platelet aggregation0ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0003540HP:0003540Impaired platelet aggregation0KCNJ1 CL E G H37586255OMIM:241200Bartter syndrome, antenatal, type 2.51
HP:0003540HP:0003540Impaired platelet aggregation0LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0003540HP:0003540Impaired platelet aggregation0MGAT2 CL E G H42477045ORPHA:79329MGAT2-CDGHP:0040283 - Occasional39
HP:0003540HP:0003540Impaired platelet aggregation0MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss297
HP:0003540HP:0003540Impaired platelet aggregation0NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome127
HP:0003540HP:0003540Impaired platelet aggregation0P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0003540HP:0003540Impaired platelet aggregation0PLA2G4A CL E G H53219035OMIM:618372GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS; GURDP2
HP:0003540HP:0003540Impaired platelet aggregation0PLAU CL E G H53289052OMIM:601709Quebec platelet disorder50
HP:0003540HP:0003540Impaired platelet aggregation0RASGRP2 CL E G H102359879OMIM:615888Bleeding disorder, platelet-type, 18.11
HP:0003540HP:0003540Impaired platelet aggregation0RUNX1 CL E G H86110471OMIM:601399Platelet disorder, familial, with associated myeloid malignancy181
HP:0003540HP:0003540Impaired platelet aggregation0SH2B3 CL E G H1001929605OMIM:187950THROMBOCYTHEMIA 1; THCYT14
HP:0003540HP:0003540Impaired platelet aggregation0TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0003540HP:0003540Impaired platelet aggregation0THPO CL E G H706611795OMIM:187950THROMBOCYTHEMIA 1; THCYT123
HP:0003540HP:0003540Impaired platelet aggregation0VWF CL E G H745012726OMIM:193400Von willebrand disease, type 1.533
HP:0003540HP:0003540Impaired platelet aggregation0VWF CL E G H745012726OMIM:277480Von willebrand disease, type 3.533
HP:0003540HP:0031130Impaired calcium ionophore-induced platelet aggregation1 CL E G H
HP:0003540HP:0031129Impaired phorbol myristate acetate-induced platelet aggregation1 CL E G H
HP:0003540HP:0031128Impaired collagen-related peptide-induced platelet aggregation1 CL E G H
HP:0003540HP:0031127Impaired convulxin-induced platelet aggregation1 CL E G H
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1AP3B1 CL E G H8546566OMIM:608233Hermansky-Pudlak syndrome 283
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1CALR CL E G H8111455OMIM:187950THROMBOCYTHEMIA 1; THCYT11
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1CALR CL E G H8111455OMIM:187950THROMBOCYTHEMIA 1; THCYT11
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1CALR CL E G H8111455OMIM:187950THROMBOCYTHEMIA 1; THCYT11
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1CISD2 CL E G H49385624212OMIM:604928Wolfram syndrome 23
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1FLI1 CL E G H23133749OMIM:617443Bleeding disorder, platelet-type, 218
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndromeHP:0040280 - Obligate23
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1GP1BA CL E G H28114439OMIM:231200BERNARD-SOULIER SYNDROME; BSS23
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndromeHP:0040280 - Obligate8
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1GP1BB CL E G H28124440OMIM:231200BERNARD-SOULIER SYNDROME; BSS8
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndromeHP:0040280 - Obligate21
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1GP9 CL E G H28154444OMIM:231200BERNARD-SOULIER SYNDROME; BSS21
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5105
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 6.45
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1IKZF5 CL E G H6437614283OMIM:619130THROMBOCYTOPENIA 7; THC7
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1IKZF5 CL E G H6437614283OMIM:619130THROMBOCYTOPENIA 7; THC7
HP:0003540HP:0011870Impaired arachidonic acid-induced platelet aggregation1IKZF5 CL E G H6437614283OMIM:619130THROMBOCYTOPENIA 7; THC7
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1IKZF5 CL E G H6437614283OMIM:619130THROMBOCYTOPENIA 7; THC7
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040284 - Very rare69
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1ITGB3 CL E G H36906156OMIM:619271BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT2480
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1ITGB3 CL E G H36906156OMIM:619271BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT2480
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1ITGB3 CL E G H36906156OMIM:619271BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT2480
HP:0003540HP:0011870Impaired arachidonic acid-induced platelet aggregation1ITGB3 CL E G H36906156OMIM:619271BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT2480
HP:0003540HP:0011871Impaired ristocetin-induced platelet aggregation1ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040284 - Very rare80
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss297
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss297
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome.127
HP:0003540HP:0011872Impaired thrombin-induced platelet aggregation1NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome.127
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1PLAU CL E G H53289052OMIM:601709Quebec platelet disorder.50
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1SH2B3 CL E G H1001929605OMIM:187950THROMBOCYTHEMIA 1; THCYT14
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1SH2B3 CL E G H1001929605OMIM:187950THROMBOCYTHEMIA 1; THCYT14
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1SH2B3 CL E G H1001929605OMIM:187950THROMBOCYTHEMIA 1; THCYT14
HP:0003540HP:0011894Impaired thromboxane A2 agonist-induced platelet aggregation1TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0003540HP:0008148Impaired epinephrine-induced platelet aggregation1THPO CL E G H706611795OMIM:187950THROMBOCYTHEMIA 1; THCYT123
HP:0003540HP:0004866Impaired ADP-induced platelet aggregation1THPO CL E G H706611795OMIM:187950THROMBOCYTHEMIA 1; THCYT123
HP:0003540HP:0008320Impaired collagen-induced platelet aggregation1THPO CL E G H706611795OMIM:187950THROMBOCYTHEMIA 1; THCYT123


Genes (34) :ABCG8 AP3B1 BLOC1S3 BLOC1S5 CALR CISD2 DTNBP1 EPHB2 FLI1 GATA1 GFI1B GP1BA GP1BB GP9 HPS3 HPS5 HPS6 IKZF5 ITGA2B ITGB3 KCNJ1 LCP2 MGAT2 MYH9 NBEAL2 P2RY12 PLA2G4A PLAU RASGRP2 RUNX1 SH2B3 TBXA2R THPO VWF

Diseases (35) :OMIM:210250 OMIM:608233 OMIM:614077 OMIM:619172 OMIM:187950 OMIM:604928 OMIM:614076 OMIM:618462 OMIM:617443 OMIM:300835 OMIM:187900 ORPHA:274 OMIM:231200 OMIM:614072 OMIM:614074 OMIM:614075 OMIM:619130 OMIM:187800 OMIM:273800 ORPHA:849 OMIM:619271 OMIM:619267 OMIM:241200 OMIM:619374 ORPHA:79329 OMIM:155100 OMIM:139090 OMIM:609821 OMIM:618372 OMIM:601709 OMIM:615888 OMIM:601399 OMIM:614009 OMIM:193400 OMIM:277480
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.